Oliver Staak
About
In The Last Decade
Oliver Staak
8 papers receiving 300 citations
Peers
Comparison fields: 5 of 41
- Pathology and Forensic Medicine 205
- Oncology 147
- Immunology 94
- Genetics 73
- Radiology, Nuclear Medicine and Imaging 72
Countries citing papers authored by Oliver Staak
This map shows the geographic impact of Oliver Staak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Staak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Staak more than expected).
Fields of papers citing papers by Oliver Staak
This network shows the impact of papers produced by Oliver Staak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Staak. The network helps show where Oliver Staak may publish in the future.
Co-authorship network of co-authors of Oliver Staak
This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Staak. A scholar is included among the top collaborators of Oliver Staak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Staak. Oliver Staak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Entwicklung von Anti-CD30-Radioimmunkonstrukten zur Behandlung des Hodgkin-Lymphoms – Studien an Zellkulturen und Tieren | 6 |
| 2 | 8 | |
| 3 | 24 | |
| 4 | 29 | |
| 5 | 48 | |
| 6 | 78 | |
| 7 | A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma. | 112 |
| 8 | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.